Skip to content
Abierto
Menu

Award notice, first published as presolicitation

Hydralazine HCL Injections Award - Hikma Pharmaceuticals

36E79725R0048

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Hikma Pharmaceuticals USA Inc.

$2,371,481.00 on the award notice, November 21, 2025, contract 36E79726D0001

Description

As published on SAM.gov with the justification of November 21, 2025.

This acquisition did not provide for full and open competition in accordance with FAR 6.302-7. While this acquisition did not provide for full and open competition, the solicitation was posted to SAM.gov and all offerors of U.S.-made product were considered. See the attached justification document for details.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Hikma Pharmaceuticals USA Inc.
UEI
NQJ5E87TKNB1
CAGE
32655
Vendor location
Berkeley Heights, NJ
Contract
36E79726D0001
Obligated
$0.00, potential $2,371,481
Actions
3 between November 21, 2025 and September 2, 2026
Competition
Full and Open Competition After Exclusion of Sources, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Hydralazine HCL Injections with Hikma Pharmaceuticals Usa, INC. Ordering Period Is 1/20/2026 - 1/19/2027 with Four ONE-YEAR Options.
Match
solicitation number 36E79725R0048 equals the FPDS solicitation identifier; same awarding office 36E797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 7, 2025

    Presolicitation

    Hydralazine Injection

    Due August 29, 2025 at 3:30 PM EDT. SAM.gov, notice 24843307a2b5497497c1cf8b769ebac5

  2. July 24, 2025

    Solicitation, originally presolicitation

    Hydralazine Injection

    Due August 25, 2025 at 3:30 PM EDT. SAM.gov, notice c0cda927eace4d7e98b3c83fbefc4c5f

  3. November 21, 2025

    Justification, originally presolicitation

    Awarded to Hikma Pharmaceuticals USA Inc. Berkeley Heights 07922 for $2,371,481. SAM.gov, notice 23b665d1663d47a08d9ebc824a044f65

  4. November 21, 2025

    Award notice, originally solicitation

    Awarded to Hikma Pharmaceuticals USA Inc. Berkeley Heights 07922 Jib for $2,371,481. SAM.gov, notice c3f1e05615594a25b581085f96a36f8b

Points of contact

Also open from this buyer